Xeltis announced the completion of enrollment in its European Union (EU) pivotal trial for the aXess restorative vascular access ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback